-
公开(公告)号:US07579346B2
公开(公告)日:2009-08-25
申请号:US10535246
申请日:2003-10-30
申请人: Dieter Dorsch , Bertram Cezanne , Werner Mederski , Christos Tsaklakidis , Hanns Wurziger , Johannes Gleitz , Christoph van Amsterdam
发明人: Dieter Dorsch , Bertram Cezanne , Werner Mederski , Christos Tsaklakidis , Hanns Wurziger , Johannes Gleitz , Christoph van Amsterdam
IPC分类号: A61K31/535 , A61K31/497 , A61K31/415 , C07D413/00 , C07D409/00 , C07D231/00 , C07D333/36
CPC分类号: C07D409/12 , C07D265/32 , C07D413/12
摘要: Novel compounds of the formula (I), in which D, W, X, Y, T, m and R1 have the meaning indicated in Patent claim 1, are inhibitors of coagulation factor Xa and can be employed for the prophylaxis and/or therapy of thromboembolic diseases and for the treatment of tumours.
摘要翻译: 式(I)的新型化合物,其中D,W,X,Y,T,m和R 1具有专利权利要求1中所示的含义,是凝血因子Xa的抑制剂,可用于预防和/或治疗 的血栓栓塞性疾病和治疗肿瘤。
-
公开(公告)号:US20060052376A1
公开(公告)日:2006-03-09
申请号:US10535246
申请日:2003-10-30
申请人: Dieter Dorsch , Bertram Cezanne , Werner Mederski , Christos Tsaklakidis , Hanns Wurziger , Johannes Gleitz , Christoph Van Amsterdam
发明人: Dieter Dorsch , Bertram Cezanne , Werner Mederski , Christos Tsaklakidis , Hanns Wurziger , Johannes Gleitz , Christoph Van Amsterdam
IPC分类号: C07D413/02 , A61K31/55 , A61K31/5377 , A61K31/4965 , A61K31/50
CPC分类号: C07D409/12 , C07D265/32 , C07D413/12
摘要: Novel compounds of the formula (I), in which D, W, X, Y, T, m and R1 have the meaning indicated in Patent claim 1, are inhibitors of coagulation factor Xa and can be employed for the prophylaxis and/or therapy of thromboembolic diseases and for the treatment of tumours.
摘要翻译: 式(I)的新型化合物,其中D,W,X,Y,T,m和R 1具有专利权利要求1中所示的含义,是凝血因子Xa的抑制剂,可以是 用于预防和/或治疗血栓栓塞性疾病和用于治疗肿瘤
-
3.
公开(公告)号:US07598241B2
公开(公告)日:2009-10-06
申请号:US10543109
申请日:2004-01-08
申请人: Dieter Dorsch , Bertram Cezanne , Werner Mederski , Christos Tsaklakidis , Johannes Gleitz , Christoph van Amsterdam
发明人: Dieter Dorsch , Bertram Cezanne , Werner Mederski , Christos Tsaklakidis , Johannes Gleitz , Christoph van Amsterdam
IPC分类号: A61K31/535 , A61K31/5375 , A61K31/4965 , A61K31/4412 , C07D265/06 , C07D241/02 , C07D213/127 , C07D295/02
CPC分类号: C07D213/64 , C07D241/18 , C07D265/06 , C07D265/10 , C07D265/32 , C07F9/58 , C07F9/59 , C07F9/650952 , C07F9/653 , C07F9/6533
摘要: Novel compounds of the formula (I) in which R1, D, X, W, Y and T have the meaning indicated in Patent Claim (1), e.g. (II), are inhibitors of coagulation factor Xa and can be employed for the prophylaxis and/or therapy of thromboembolic diseases and for the treatment of tumors.
摘要翻译: 式(I)的新型化合物,其中R 1,D,X,W,Y和T具有专利权利要求(1)所述的含义, (II)是凝血因子Xa的抑制剂,可用于预防和/或治疗血栓栓塞性疾病和治疗肿瘤。
-
公开(公告)号:US20060084648A1
公开(公告)日:2006-04-20
申请号:US10547130
申请日:2004-01-30
申请人: Werner Mederski , Christos Tsaklakidis , Dieter Dorsch , Bertram Cezanne , Johannes Gleitz , Christoph van Amsterdam
发明人: Werner Mederski , Christos Tsaklakidis , Dieter Dorsch , Bertram Cezanne , Johannes Gleitz , Christoph van Amsterdam
IPC分类号: A61K31/537 , A61K31/4172 , C07D265/30 , C07D413/02
CPC分类号: C07D213/64 , C07D233/46 , C07D265/32 , C07D401/12 , C07D403/12 , C07F9/6533
摘要: Novel compounds of the formula (I), in which R1, R2, R3, X and Y have the meaning indicated in Patent claim 1, are inhibitors ocoagulation factor Xa and can be employed for the prophylaxis and/or therapy of thromboembolic diseases and for the treatment of tumours.
摘要翻译: 式(I)的新化合物,其中R 1,R 2,R 3,X和Y具有专利中所示的含义 权利要求1是抑制凝血因子Xa,可用于预防和/或治疗血栓栓塞性疾病和治疗肿瘤。
-
公开(公告)号:US07427618B2
公开(公告)日:2008-09-23
申请号:US10547130
申请日:2004-01-30
申请人: Werner Mederski , Christos Tsaklakidis , Dieter Dorsch , Bertram Cezanne , Johannes Gleitz , Christoph van Amsterdam
发明人: Werner Mederski , Christos Tsaklakidis , Dieter Dorsch , Bertram Cezanne , Johannes Gleitz , Christoph van Amsterdam
IPC分类号: C07D265/32 , C07D233/46 , C07D213/64 , C07D413/12 , A61K31/5375 , A61K31/5377 , A61K31/4168 , A61K31/4412
CPC分类号: C07D213/64 , C07D233/46 , C07D265/32 , C07D401/12 , C07D403/12 , C07F9/6533
摘要: Novel compounds of the formula (I), in which R1, R2, R3, X and Y have the meaning indicated in Patent claim 1, are inhibitors of coagulation factor Xa and can be employed for the prophylaxis and/or therapy of thromboembolic diseases and for the treatment of tumors.
摘要翻译: 式(I)的新化合物,其中R 1,R 2,R 3,X和Y具有专利中所示的含义 权利要求1是凝血因子Xa的抑制剂,可用于预防和/或治疗血栓栓塞性疾病和治疗肿瘤。
-
6.
公开(公告)号:US20060074072A1
公开(公告)日:2006-04-06
申请号:US10543109
申请日:2004-01-08
申请人: Dieter Dorsch , Bertram Cezanne , Werner Mederski , Christos Tsaklakidis , Johannes Gleitz , Christoph Van Amsterdam
发明人: Dieter Dorsch , Bertram Cezanne , Werner Mederski , Christos Tsaklakidis , Johannes Gleitz , Christoph Van Amsterdam
IPC分类号: A61K31/675 , A61K31/5513 , A61K31/5377 , A61K31/496 , A61K31/495 , A61K31/4545 , A61K31/444 , C07D413/02 , C07D403/02 , C07D401/02
CPC分类号: C07D213/64 , C07D241/18 , C07D265/06 , C07D265/10 , C07D265/32 , C07F9/58 , C07F9/59 , C07F9/650952 , C07F9/653 , C07F9/6533
摘要: Novel compounds of the formula (I) in which R1, D, X, W, Y and T have the meaning indicated in Patent Claim (1), e.g. (II), are inhibitors of coagulation factor Xa and can be employed for the prophylaxis and/or therapy of thromboembolic diseases and for the treatment of tumours.
摘要翻译: 其中R 1,D,X,W,Y和T的新的式(I)化合物具有专利权利要求(1)所述的含义,例如, (II)是凝血因子Xa的抑制剂,可用于预防和/或治疗血栓栓塞性疾病和治疗肿瘤。
-
公开(公告)号:US20060217550A1
公开(公告)日:2006-09-28
申请号:US10567848
申请日:2004-07-16
IPC分类号: C07D265/32
CPC分类号: C07D265/32
摘要: The invention relates to a method for production of compounds of formula (I), where X has the meaning given in claim 1 and precursors for the same.
摘要翻译: 本发明涉及一种制备式(I)化合物的方法,其中X具有权利要求1中给出的含义及其前体。
-
公开(公告)号:US07687624B2
公开(公告)日:2010-03-30
申请号:US10567848
申请日:2004-07-16
IPC分类号: C07D295/073 , C07D295/10
CPC分类号: C07D265/32
摘要: The invention relates to a method for production of compounds of formula (I), where X has the meaning given in claim 1 and precursors for the same.
摘要翻译: 本发明涉及制备式(I)化合物的方法,其中X具有权利要求1中给出的含义及其前体。
-
公开(公告)号:US07732481B2
公开(公告)日:2010-06-08
申请号:US10583094
申请日:2004-11-26
IPC分类号: A61K31/4015 , C07D207/04
CPC分类号: C07D207/16 , C07D401/12
摘要: Novel compounds of the formula (I), in which R, R1, R2, R3, X, X′ and Y have the meaning indicated in Patent Claim 1, are inhibitors of coagulation factor Xa and can be employed for the prophylaxis and/or therapy of thromboembolic diseases and for the treatment of tumors.
摘要翻译: 式(I)的新型化合物,其中R,R 1,R 2,R 3,X,X'和Y具有专利权利要求1中所示的含义,是凝血因子Xa的抑制剂,可用于预防和/或 治疗血栓栓塞性疾病和治疗肿瘤。
-
公开(公告)号:US20070123509A1
公开(公告)日:2007-05-31
申请号:US10582850
申请日:2004-11-19
IPC分类号: A61K31/55 , A61K31/5377 , A61K31/497 , A61K31/496 , C07D413/02 , C07D403/02
CPC分类号: C07D213/74 , C07D211/16 , C07D211/26 , C07D211/32 , C07D211/46 , C07D211/52 , C07D211/58 , C07D213/38 , C07D239/42 , C07D295/192 , C07D333/24 , C07D401/04 , C07D409/06 , C07D409/14 , C07D487/08
摘要: Novel compounds of the formula (I) in which D, E, Q, T, X, Y, Z, Z′, R1, R4 and R4′ have the meanings indicated in patent Claim 1, are inhibitors of coagulation factor Xa and can be employed for the prophylaxis and/or therapy of thromboembolic diseases and for the treatment of tumours
摘要翻译: 其中D,E,Q,T,X,Y,Z,Z',R 1,R 4和R 4的新的式(I)化合物 > 4'具有专利权利要求1所述的含义,是凝血因子Xa的抑制剂,可用于预防和/或治疗血栓栓塞性疾病和治疗肿瘤
-
-
-
-
-
-
-
-
-